Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Jachetti

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Scientific Reports|January 13, 2021
Immune-tolerance to human iPS-derived neural progenitors xenografted into the immature cerebellum is overridden by species-specific differences in differentiation timingGiulia Nato, Alessandro Corti, Elena Parmigiani, et al.
International Journal of Molecular Sciences|February 12, 2020
Gene Expression Signature Predictive of Neuroendocrine Transformation in Prostate AdenocarcinomaPaola Ostano, Maurizia Mello-Grand, Debora Sesia, et al.
Molecular Cancer Therapeutics|December 17, 2008
Critical role of indoleamine 2,3-dioxygenase in tumor resistance to repeated treatments with targeted IFNgammaAnna Maria Gasparri, Elena Jachetti, Barbara Colombo, et al.
Stem Cells Translational Medicine|July 26, 2013
Gene signatures distinguish stage-specific prostate cancer stem cells isolated from transgenic adenocarcinoma of the mouse prostate lesions and predict the malignancy of human tumorsStefania Mazzoleni, Elena Jachetti, Sara Morosini, et al.
Oncotarget|December 25, 2015
Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancersGiorgio Mauri, Elena Jachetti, Barbara Comuzzi, et al.
Cancer Research|January 4, 2008
Peripheral T-cell tolerance associated with prostate cancer is independent from CD4+CD25+ regulatory T cellsElena Degl'Innocenti, Matteo Grioni, Giusy Capuano, et al.
The Prostate|April 26, 2008
Vasculature-targeted tumor necrosis factor-alpha increases the therapeutic index of doxorubicin against prostate cancerMaria T S Bertilaccio, Matteo Grioni, Brent W Sutherland, et al.
Oncoimmunology|June 14, 2013
Prostate cancer stem cells are targets of both innate and adaptive immunity and elicit tumor-specific immune responsesElena Jachetti, Stefania Mazzoleni, Matteo Grioni, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 13, 2009
Characterization of preclinical models of prostate cancer using PET-based molecular imagingSara Belloli, Elena Jachetti, Rosa M Moresco, et al.
Circulation Research|August 19, 2020
T Cell Costimulation Blockade Blunts Age-Related Heart FailureElisa Martini, Marco Cremonesi, Cristina Panico, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Scientific Reports|January 13, 2021
Immune-tolerance to human iPS-derived neural progenitors xenografted into the immature cerebellum is overridden by species-specific differences in differentiation timingGiulia Nato, Alessandro Corti, Elena Parmigiani, et al.
International Journal of Molecular Sciences|February 12, 2020
Gene Expression Signature Predictive of Neuroendocrine Transformation in Prostate AdenocarcinomaPaola Ostano, Maurizia Mello-Grand, Debora Sesia, et al.
Molecular Cancer Therapeutics|December 17, 2008
Critical role of indoleamine 2,3-dioxygenase in tumor resistance to repeated treatments with targeted IFNgammaAnna Maria Gasparri, Elena Jachetti, Barbara Colombo, et al.
Stem Cells Translational Medicine|July 26, 2013
Gene signatures distinguish stage-specific prostate cancer stem cells isolated from transgenic adenocarcinoma of the mouse prostate lesions and predict the malignancy of human tumorsStefania Mazzoleni, Elena Jachetti, Sara Morosini, et al.
Oncotarget|December 25, 2015
Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancersGiorgio Mauri, Elena Jachetti, Barbara Comuzzi, et al.
Cancer Research|January 4, 2008
Peripheral T-cell tolerance associated with prostate cancer is independent from CD4+CD25+ regulatory T cellsElena Degl'Innocenti, Matteo Grioni, Giusy Capuano, et al.
The Prostate|April 26, 2008
Vasculature-targeted tumor necrosis factor-alpha increases the therapeutic index of doxorubicin against prostate cancerMaria T S Bertilaccio, Matteo Grioni, Brent W Sutherland, et al.
Oncoimmunology|June 14, 2013
Prostate cancer stem cells are targets of both innate and adaptive immunity and elicit tumor-specific immune responsesElena Jachetti, Stefania Mazzoleni, Matteo Grioni, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 13, 2009
Characterization of preclinical models of prostate cancer using PET-based molecular imagingSara Belloli, Elena Jachetti, Rosa M Moresco, et al.
Circulation Research|August 19, 2020
T Cell Costimulation Blockade Blunts Age-Related Heart FailureElisa Martini, Marco Cremonesi, Cristina Panico, et al.
Pageof 5